Loading...
Agenda Item - 2022-11-15 - Number 11.2 - Presentation - Sam Chapman of Healing Advocacy Fund 11 .2 Healing Measure 109 Cj Advocacy Program Overview for Fund Psilocybin Therapy in Oregon y n" 4 - J' Our Mission : • ,„. The Healing Advocacy Fund is a 501c3 nonprofit dedicated to - supporting the thoughtful and effective development, \ implementation, and education of the nation's first regulated \ _ psilocybin therapy program, which Oregon voters passed : ,'� through Measure 109 in November 2020. t : -,-, ,ram- f Healing `= CjAdvocacy -4 Fund - _ Measure 109 Recap c Oregonians Are Suffering Now, More Than ever 1 . According to a recent survey conducted by CDCs National Center for Health Statistics and the Census Bureau: At the start of the COVID-19 pandemic, 1 in 5 Americans were experiencing symptoms of clinical anxiety or depression, but now over a third of Oregonians say they are experiencing symptoms amid the country's coronavirus pandemic. 2. Here in Oregon, the mental health crisis is even more acute. According to Mental Health America, Oregon's mental health crisis is the 3rd worst in the country. Psilocybin Re s e arch ,# MEDICAL SCHOOL qv 5LIl �.<< DspernmaS PsychhSTANFoR ) = � HARVARD ( r • Rigorous studies at the leading medical PURDUE JOHNS HOPKINS Ilk ft research institutions such as Johns COLLEGE OF YkIggMACT MIDICINI Hopkins, UCLA, University of Alabama and LICE ALA UNIVERSITY Z M ALABAMA A7$IRMINGHAM C4LVM8IA'UNIVHBSI-i'Y MEDICAL CENTER University Up NYU show that psilocybin works. It is tat,University of tZ department of BRISTOL Veterans Affairs LABioMed uniquely effective in treating depression, Irn.in Bl .7.,.al rip McLean HOSPITAL 7,1`.'I,Sut RLam l Blum ka end-of-life anxiety, and addiction. ' Perelman 41; School of Mtdicinr Rcse,rh lnriltu r Imperial College • It shows so much promise the FDA London ►� Harbor-UCLA K��vc:�•s ,w recently granted it a 'breakthrough co«Vg� Faculty of Medicine 1.ONDON therapy"designation - meaning that it NHS Greater Manchester l()1Z61,; I t ���� may demonstrate substantial 0 Utrecht University Mental Health 47"1' NIi5 Faundatloe Trust improvement above and beyond what is currently available. The Measure 109 GOAL: Create licensing and IN'l : regulatory framework to serve A measured those who seek Psilocybin Therapy and could safely benefit approach from it. What Measure 109 Does • Establishes aegulatory framework within the Oregon Health Authority (OHA) that will allow trained practitioners to administer psilocybin services at specially licensed centers • Establishes the Oregon Psilocybin Advisory Board, appointed by the Governor • Imposes a two-year development period before initial licenses are granted • Requires the establishment of a training and licensure system for psilocybin facilitators,psilocybin manufacturers, and testing labs • Requires the establishment of a tracking system for psilocybin products Psilocybin Services A Four Step Process to ensure public health and safety o ASSESSMENT /��///'/� Participants complete 1! a screening process and match with a psilocybin facilitator based on individual needs and fit. (lc) 0 INTENTION-SETTING Facilitator meets with 0 The Oregon Model participant for a preparation session to explain the delivers psilocybin process,incorporate INTEGRATION SESSION services in a participant goals and develop an individualized Participant meets with four-step process safety plan. their facilitator to integrate insights and learning from i jithe psilocybin experience into doily life. 0 0 0 0 ADMINISTRATION SESSION 410 Ps€locybin is administered at a licensed service center by a trained facilitator,who oversees the session and supports the participant throughout. • Retail sales • Off-site consumption, possession, M 10 9 doe s or production • Unregulated or untracked NO T a lb v : psilocybin production, delivery, or inventory • Service centers near schools • Access for minors Implementation Overview • Measure 109 establishes an initialo-year development period. • During that period,the Oregon Health Authority,with the guidance of an Advisory Board,will study psilocybin research and science and develop a regulatory program,including rules, training requirements, and licensing requirements. • In January 2023,at the completion of the two-year study period, OHAwill begin accepting applications and issuing licenses to: o Facilitate psilocybin service administration sessions, o manufacture psilocybin products, o operate psilocybin service centers o test psilocybin products Implementation Timeline Feb. 2021 Governor June 2022 makes Advisory Board Jan, 1st. 2020 appointments makes Jan. 2023 Psiloc bin June 2021 OHA be ins y to Advisory recommendations g Advisory Board Board Advisory Board for rules and accepting application reports science regulations license process closes and research applications findings T Planning Research Rule-Making Dec. 2020 Jan. 19th 2021 Mar. 2021 July 2021 Psilocybin Legislative Advisory OHA Dec. 2022 Advisory Board session begins Board's first publishes OHA adopts application meeting psilocybin rules and process opens science and regulations research Local Control Overview Measure 109 set a foundation of state rules and regulations for psilocybin progran licensee 's to operate within cities and counties. Measure 109 also gives local governments the option to create additional time place and manner restrictions on Service Centers and Manufacturers. The base program exists throughout the state unless voters choose to opt-out by local ordinance on a general election ballot. Pub lic S a fe ty & Restrictions Psilocybin service centers can not locate: • Within an area zoned exclusively for residential use in Cities. • Within 1,000 feet of a school Psilocybin manufacturers can not locate: • Within a residence or mixedse property that includes a residence. • Within an area zoned for residential use. Secure Storage • All psilocybin products shall be secured within a licensed facility in locked storage accessible only to employees of the licensed facility. Sales • Sales or any other transfers of psilocybin must occur inside the licensed premises On-Site Use Only • Psilocybin and psilocybin products can only be ingested at licensed service centers. Support for M109 was broad and statewide Measure 109 Permits licensed service providers to administer psilocybin-producing mushroom and fungi products to individuals 21 years of age or older. • Benton 63.4% Yes: 1,270,057 55.7% No: 1,008,199 44.3% • Clackamas (52.4%) P. • Clatsop (54.9%) 1 III all , • Columbia (50.6) • Curry (50.3%) • Deschutes (52.6%) • Hood River (63.2%) • Jackson (51.1%) iippig -J040- I / TTI • Lane (59.9%) ( • Lincoln (57.6%) • Multnomah (71.2%) • Tillamook (51.4%) • Wasco (50.4%1 • Washington (59.1%) MI • Yamhill (50.1%) um 40%50%60% 40% 50%60% Yes No Source:The Oregonian (2020) Questions ? Sam Chapman Thank You Executive Director Sam@flealingadvocacyfund.org